Skip to main content

Ketolysis Defects

  • Chapter
Inborn Metabolic Diseases
  • 308 Accesses

Summary

The serum concentration of ketone bodies [acetoacetate (AA) + D 3-hydroxybutyrate (3OHB)] represents the balance between their production by the liver and their utilization by peripheral tissues. After a 24-h fast, in normal children aged between 1 and 7 years ketone body levels of 3–6 mmol/liter are reached [1–5]. By analogy to the definition of lactic acidosis, a ketoacidosis is considered to occur when concentrations of ketone bodies are greater than 7 mmol/liter [6]. Many metabolic disorders of childhood may lead to ketoacidosis including insulin-dependent diabetes, the inborn errors of branched-chain amino acid catabolism (MSUD, MMA, PA, IVA), the congenital lactic acidoses like multiple carboxylase and pyruvate carboxylase deficiencies, and inherited defects in enzymes of gluconeogenesis. In these four categories of disorder, hyperketosis is thought to be mainly related to an excess of ketone body production. As opposed to these disorders, hyperketotic states due to ketolytic defects are mainly associated with decreased peripheral ketone body utilization. 3-Oxoacid CoA transferase (3OAT) deficiency is a very rare autosomal recessive disorder characterized by recurrent attacks of severe ketoacidosis with or without hypoglycemia, low lactacidemia, and low ammonemia. Intravenous glucose infusion results in a rapid improvement. Investigation of urinary organic acids during attacks demonstrates the presence of high concentrations of 3OHB and AA only without any other specific organic acids. Clinical diagnosis depends on the evidence of a permanent ketosis both in urine (acetest+) and in plasma (3OHB+AA more than 0.2 mmol/l even in the postprandial period) with a tendency to increase from morning through the day. A fasting test results in a highly abnormal increase in blood ketones, compared with the simultaneous blood glucose and free fatty acid levels. Ketosis is also related to the protein intake and can be triggered by a leucine-loading test. The diagnosis can be confirmed by the demonstration in cultured fibroblasts of a defective C14 AA oxidation and on the very low enzymatic activity of 3OAT.

Mitochondrial acetoacetyl CoA thiolase (AAT) and 2-methyl acetoacetyl CoA thiolase (2MAAT) deficiencies present with very similar clinical and biological pictures. The most frequent presentation is recurrent attacks of severe ketoacidosis, reversed by bicarbonate and glucose infusion. Both conditions are triggered by catabolism, during intercurrent infectious diseases, fasting, and high protein intake. In 2MAAT the urinary organic profile is highly characteristic with association of 3OHB, 2-methyl 3OHB, and tiglylglycine. Excretion of the last two compounds is largely dependent on the protein intake, and during the remission phases can be elicited by acute or chronic isoleucine load. These compounds have not been found in any case of AAT deficiency. Differentiation of the two conditions depends on the study in cultured fibroblasts of K-dependent mitochondrial activities of AAT, and 2MAAT using C14 AACoA and C14 2MAACoA as substrates. Treatment of these disorders consists of avoiding prolonged fast and of a moderately protein restricted diet. One gram sodium bicarbonate should be given orally every 8 h when the acetest is 3 +.

Cytosolic AAT deficiency is a rather different disorder, which presents with severe mental retardation, hypotonia, and a tendency for ketone bodies to accumulate, without significant organic acid excretion. This condition could easily be missed as its clinical presentation is nonspecific and persistent ketosis may be the only initial abnormality. No efficient treatment is available.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lamers KJB, Doesburg WH, Gabreëls FJM, Romsom AC, Renier WO, Wevers RA, Lem-mens WAJG (1985) Reference values of blood components related to fuel metabolism in children after an overnight fast. Clin Chim Acta 145: 17–26

    Article  PubMed  CAS  Google Scholar 

  2. Persson B, Gentz J (1966) The pattern of blood lipids, glycero and ketone bodies during the neonatal period, infancy and childhood. Acta Paediatr Scand 55: 353–362

    PubMed  CAS  Google Scholar 

  3. Persson B, Settergren G, Dahlquist G (1972) Cerebral arteriovenous difference of acetoacetate and 3-hydroxybutyrate in children. Acta Paediatr Scand 61: 273–278

    Article  PubMed  CAS  Google Scholar 

  4. Saudubray JM, Marsac C, Limal JM, Dumurgier E, Charpentier C, Ogier H, Coudé FX (1981) Variation in plasma ketone bodies during a 24-hour fast in normal and in hypoglycemic children. J Pediatr 98: 904–908

    Article  PubMed  CAS  Google Scholar 

  5. Settergren G, Lindblad BS, Persson B (1976) Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate and amino acids in infants. Acta Paediatr Scand 65: 343–353

    Article  PubMed  CAS  Google Scholar 

  6. Robinson AM, Williamson DH (1980) Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 60: 143–187

    PubMed  CAS  Google Scholar 

  7. Middleton B (1973) The oxoacyl-CoA thiolases of animal tissues. Biochem J 132: 710–730

    Google Scholar 

  8. Middleton B (1978) Enzymatic aspects of ketone body metabolism: the role of mitochondria) acetoacetyl CoA thiolase isoenzymes. In: Solving HD, Suefert CD (eds) Biochemical and clinical aspects of ketone body metabolism. Thieme, Stuttgart, pp 1–9

    Google Scholar 

  9. Hartlage P, Eller G, Carter L, Roesel A, Hommes F (1986) Mitochondrial acetoacetyl-CoA thiolase deficiency. Biochem Med Metab Biol 36: 198–206

    Article  PubMed  CAS  Google Scholar 

  10. Hommes FA, Shapira E (1988) Variable presentations of acetoacetyl CoA thiolase deficiencies. Fatty Acid Oxidation Meeting, Nov 9–12, Philadelphia

    Google Scholar 

  11. Tildon JT, Cornblath M (1972) Succinyl-CoA: 3-ketoacid CoA-transferase deficiency. A cause for ketoacidosis in infancy. J Clin Invest 51: 493–498

    Google Scholar 

  12. Spence MW, Murphy MG, Cook HW, Ripley BA, Embil JA (1973) Succinyl CoA: 3 ketoacid CoA transferase deficiency. A “new” phenotype ( Abstr ). Pediatr Res 7: 394

    Google Scholar 

  13. Saudubray JM, Specola N, Middleton B, et al. (1987) Hyperketotic states due to inherited defects of ketolysis. Enzyme 38: 80–90

    PubMed  CAS  Google Scholar 

  14. Daum RS, Marner OA, Lamm PH, Scriver CR (1971) A “new” disorder of isoleucine catabolism. Lancet 2: 1289–1290

    Article  PubMed  CAS  Google Scholar 

  15. Daum RS, Scriver CR, Marner OA, Delvin E, Lamm P, Goldman H (1973) An inherited disorder of isoleucine catabolism causing accumulation of 2-methylacetoacetate and 2-methyl-/3-hydroxybutyrate, and intermittent metabolic acidosis. Pediatr Res 7: 149–160

    Article  PubMed  CAS  Google Scholar 

  16. De Klerck JBC, Duran M, van Overbeek-van Bils ALT, van Sprang FJ, Middleton B, Wadman SK (1986) /i-Ketothiolase deficiency in twin brothers. Metabolic studies related to dietary treatment (Abstr 51 ). SSIEM, Amersfoort

    Google Scholar 

  17. Gompertz D, Saudubray JM, Charpentier C, Bartlett K, Goodey PA, Draffan GH (1974) A defect in r-isoleucine metabolism associated with 2-methyl-3-hydroxybutyric and 2-methylacetoacetic aciduria: quantitative in vivo and in vitro studies. Clin Chim Acta 57: 269–281

    Article  PubMed  CAS  Google Scholar 

  18. Halvorsen S, Stokke O, Jellum E (1979) A variant form of 2-methyl 3-hydroxybutyric and 2-methylacetoacetic aciduria. Acta Paediatr Scand 68: 123–128

    Article  PubMed  CAS  Google Scholar 

  19. Hillman RE, Keating PJ (1974) Beta-ketothiolase deficiency as a cause of the “ketotic hyperglycinemia syndrome”. Pediatrics 53: 221–225

    PubMed  CAS  Google Scholar 

  20. Hiyama K, Sakura N, Matsumoto T, Kuhara T (1986) Deficient beta-ketothiolase activity in leukocytes from a patient with 2-methylacetoacetic aciduria. Clin Chim Acta 155: 189–194

    Article  PubMed  CAS  Google Scholar 

  21. Leonard JV, Middleton B, Seakins JWT (1987) Acetoacetyl CoA thiolase deficiency presenting as ketotic hypoglycemia. Pediatr Res 21: 211–213

    Article  PubMed  CAS  Google Scholar 

  22. Middleton B, Bartlett K (1983) The synthesis and characterization of 2-methylacetoacetyl coenzyme A and its use in the identification of the site of the defect in 2-methylacetoacetic and 2-methyl-3-hydroxybutyric aciduria. Clin Chim Acta 128: 291–305

    Article  PubMed  CAS  Google Scholar 

  23. Middleton B, Gray RGF, Bennett MJ (1984) Two cases of beta-ketothiolase deficiency: a comparison. J Inherited Metab Dis 7: 131–132

    Article  PubMed  Google Scholar 

  24. Robinson BH, Sherwood WG, Taylor J, Balfe JW, Marner OA (1979) Acetoacetyl CoA thiolase deficiency: a cause of severe ketoacidosis in infancy simulating salicylism. J Pediatr 95: 228–233

    Article  PubMed  CAS  Google Scholar 

  25. Schutgens RBH, Middleton B, Bliij JF, Oorthuys JWE, Veder HA, Vulsma T, Tegelaers WHH (1982) Beta-ketothiolase deficiency in a family confirmed by in vitro enzymatic assays in fibroblasts. Eur J Pediatr 139: 39–42

    Article  PubMed  CAS  Google Scholar 

  26. Yamaguchi S, Orii T, Sakura N, Miyazama S, Hashimoto T (1988) Defect in biosynthesis of mitochondrial acetoacetyl-coenzyme A thiolase in cultured fibroblasts from a boy with 3-ketothiolase deficiency. J Clin Invest 81: 813–817

    Article  PubMed  CAS  Google Scholar 

  27. Bennet MJ, Hosking GP, Smith MF, Gray RGF, Middleton B (1984) Biochemical investigations on a patient with a defect in cytosolic acetoacetyl-CoA thiolase, associated with mental retardation. J Inherited Metab Dis 7: 125–128

    Article  Google Scholar 

  28. De Groot CJ, Luit de Haan G, Hulstaert CE, Hommes FA (1977) A patient with severe neurologic symptoms and acetoacetyl-CoA thiolase deficiency. Pediatr Res 11: 1112–1116

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Saudubray, JM., Specola, N. (1990). Ketolysis Defects. In: Fernandes, J., Saudubray, JM., Tada, K. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02613-7_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02613-7_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-02615-1

  • Online ISBN: 978-3-662-02613-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics